SCHEMBL7604560

SCHEMBL7604560

COc1ccc(C(C)C(=O)OP(=O)(O)Cc2ccccc2)c(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
AOC3 Q16853 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ACHE P22303 1/20 0.35
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5053245 0.80 PKM (0.39) PKMNPC1RAB9AKMT2AMEN1
SCHEMBL490577 0.78 ALOX5 (0.47) PKMTAS1R3TAS1R1KMT2AKDM4E
SCHEMBL7605254 0.77 ACP3 (0.41) KMT2AMEN1PTGS1PTGS2HPGD
SCHEMBL5054715 0.75 MMP1 (0.39) PKMNPC1RAB9AKMT2AMEN1
SCHEMBL7609438 0.75 ACP3 (0.50) KMT2AMEN1LMNA
SCHEMBL5051286 0.74 PKM (0.41) PKMNPC1RAB9AKMT2AMEN1
SCHEMBL490607 0.73 AOC3 (0.46) KMT2AMEN1SMN1; SMN2POLBAOC3
SCHEMBL8460467 0.72 PKM (0.43) PKMNPC1RAB9AKMT2AMEN1
SCHEMBL490403 0.72 PTGS2 (0.51) KMT2AAOC3KDM4EPTGS1PTGS2
SCHEMBL7609596 0.72 LAP3 (0.44) NPC1RAB9AKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed